Prognosis and imaging-time of chemotherapy on 18F-FDG PET/CT and MYC gene rearrangement in patients with diffuse large B-cell lymphoma

Conclusion SUVmax% in the different phase of chemotherapy and MYC gene have better values for predicting the prognosis of DLBCL, and we therefore recommend 18F-FDG PET/CT imaging be performed between 1 course and 4 cources of chemotherapy. [Key words] Lymphoma, large B-cell, diffuse; Chemotherapy; Tomography, emission-computed; Tomography, X-ray computed; Deoxygucose; MYC gene rearrangement

Source: Journal of Nuclear Medicine - May 23, 2018 Category: Nuclear Medicine Authors: Yuan, L., Wu, Z., Liu, J., Li, S. Tags: Leukemia/Lymphoma/Myeloma Poster Session Source Type: research